| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 110,764 | 112,093 | 97,299 | 111,058 | | Cost of Revenue | 22,637 | 23,753 | 19,846 | 23,264 | | | Gross Profit | 88,127 | 88,340 | 77,453 | 87,794 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| (2,425) | | Selling General and Administrative | 76,213 | 75,040 | 67,220 | 82,901 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,914 | 13,300 | 10,233 | 7,318 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 215 | 271 | 199 | (705) | | Earnings Before Interest And Taxes | 12,129 | 13,571 | 10,432 | 6,613 | | Interest Expense | 105 | 146 | 289 | 346 | | Income Before Tax | 12,024 | 13,425 | 10,143 | 6,267 | | Income Tax Expense | 4,112 | 4,634 | 3,497 | 2,156 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,912 | 8,791 | 6,646 | 4,111 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,912 | 8,791 | 6,646 | 4,111 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,912 | $8,791 | $6,646 | $4,111 |
|
1.27% Nasdaq 
Income Statement
